Tower International Inc (TOWR) Jumps 6.05% on February 22

Equities Staff |

Tower International Inc (TOWR) was among the biggest gainers on the Russell 2000 for Monday February 22 as the stock popped 6.05% to $21.73, representing a gain of $1.24 per share. Some 221,415 shares traded hands on 1,868 trades, compared with an average daily volume of 162,766 shares out of a total float of 21.11 million. The stock opened at $20.68 and traded with an intraday range of $22.11 to $20.68.

After today's gains, Tower International Inc reached a market cap of $458.68 million. Tower International Inc has had a trading range between $31.41 and $19.36 over the last year, and it had a 50-day SMA of $24.53 and a 200-day SMA of $26.07.

The stock has a P/E Ratio of 2.3.

Tower International Inc is a manufacturer of engineered automotive structural metal components and assemblies. It offers body-structure stampings, frame and other chassis structures, and complex welded assemblies for small and large cars.

Tower International Inc is based out of Livonia, MI and has some 7,800 employees. Its CEO is Mark Malcolm.

For a complete fundamental analysis analysis of Tower International Inc, check out’s Stock Valuation Analysis report for TOWR. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…


Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…